Oxaliplatin Add-On Not Recommended for Elderly With Colon Ca

The addition of oxaliplatin does not extend progression-free survival in elderly patients with metastatic colorectal cancer and in fact, can lead to more severe adverse events.

Related Keywords

Boston , Massachusetts , United States , Japan , Saitama , Lebanon , American , Roche Genentech , Tetsuya Hamaguchi , Gabriel Brooks , American Society For Clinical Oncology , Saitama Medical University International Center , National Cancer Center Research , American Society For Radiation Oncology , Agency For Medical Research , Society Of Surgical Oncology , Hitchcock Norris Cotton Cancer Center , Development Fund , American Gastroenterological Association , Clinical Cancer Research , Dartmouth Hitchcock Norris Cotton Cancer Center , Performance Status , Medical Research , Boston Biomedical , Bristol Myers Squibb Japan , Gastrointestinal Cancers Symposium , American Society , Clinical Oncology , Radiation Oncology , Colorectal Cancer , Colon Cancer , Alignant Colon Neoplasm , Neuropathy , Antiangiogenesis , Angiogenesis Inhibitor , Evacizumab , Nhibitor Angiogenesis , Elderly Concerns Of Older Adults , Geriatrics Elder Care , Sensory Neuropathy , Clinical Research , Clinical Trials , Linical Studies , Diarrhea , Fatigue , Gastrointestinal Malignancy , I Malignancy , Hypertension , Nausea , Neutropenia ,